Arcellx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Arcellx and other ETFs, options, and stocks.About ACLX
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M.
CEORami Elghandour
CEORami Elghandour
Employees163
Employees163
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2014
Founded2014
Employees163
Employees163
ACLX Key Statistics
Market cap3.96B
Market cap3.96B
Price-Earnings ratio-17.47
Price-Earnings ratio-17.47
Dividend yield—
Dividend yield—
Average volume1.56M
Average volume1.56M
High today$75.03
High today$75.03
Low today$66.00
Low today$66.00
Open price$72.20
Open price$72.20
Volume2.12M
Volume2.12M
52 Week high$94.07
52 Week high$94.07
52 Week low$47.86
52 Week low$47.86
Stock Snapshot
As of today, Arcellx(ACLX) shares are valued at $68.45. The company's market cap stands at 3.96B, with a P/E ratio of -17.47.
On 2025-12-05, Arcellx(ACLX) stock traded between a low of $66.00 and a high of $75.03. Shares are currently priced at $68.45, which is +3.7% above the low and -8.8% below the high.
The Arcellx(ACLX)'s current trading volume is 2.12M, compared to an average daily volume of 1.56M.
In the last year, Arcellx(ACLX) shares hit a 52-week high of $94.07 and a 52-week low of $47.86.
In the last year, Arcellx(ACLX) shares hit a 52-week high of $94.07 and a 52-week low of $47.86.
Analyst ratings
88%
of 17 ratingsBuy
88.2%
Hold
11.8%
Sell
0%
People also own
Based on the portfolios of people who own ACLX. This list is generated using Robinhood data, and it’s not a recommendation.